Holdings of Nomura Healthcare Fund
Delaware Group Equity Funds IV · Original filing · Compare with another fund · Report an error
- Net assets
- 750.2M $ including 711.3M $ in equities, 94.8 %
- Positions
- 99 in 13 countries
- Top ten
- 38.9 % of net assets
- Filed on
- Jun 30, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | UCB SA | 130,137 | 39M $ | 5.19 % |
| 2 | AbbVie Inc | 125,000 | 31.5M $ | 4.19 % |
| 3 | Eli Lilly & Co | 26,000 | 31.2M $ | 4.16 % |
| 4 | Regeneron Pharmaceuticals Inc | 47,000 | 29.3M $ | 3.91 % |
| 5 | UnitedHealth Group Inc | 70,000 | 29.1M $ | 3.88 % |
| 6 | Pfizer Inc | 1,195,000 | 28.8M $ | 3.84 % |
| 7 | Merck & Co Inc | 215,000 | 27.6M $ | 3.68 % |
| 8 | Gilead Sciences Inc | 210,000 | 26.5M $ | 3.54 % |
| 9 | AstraZeneca PLC | 131,243 | 24.5M $ | 3.27 % |
| 10 | Elevance Health Inc | 63,000 | 24.4M $ | 3.25 % |
| 11 | Chugai Pharmaceutical Co Ltd | 450,000 | 20.8M $ | 2.77 % |
| 12 | VIATRIS INC | 1,170,018 | 18.6M $ | 2.48 % |
| 13 | ORUKA THERAPEUTICS INC | 190,000 | 18.1M $ | 2.41 % |
| 14 | Halozyme Therapeutics Inc | 220,000 | 17.2M $ | 2.30 % |
| 15 | Amgen Inc | 47,000 | 17M $ | 2.27 % |
| 16 | Illumina Inc | 90,000 | 15.8M $ | 2.11 % |
| 17 | Alkermes PLC | 260,000 | 13.6M $ | 1.82 % |
| 18 | Viking Therapeutics Inc | 330,100 | 12.9M $ | 1.72 % |
| 19 | Vertex Pharmaceuticals Inc | 25,000 | 12.4M $ | 1.66 % |
| 20 | Roivant Sciences Ltd | 338,181 | 12M $ | 1.60 % |
| 21 | Neurocrine Biosciences Inc | 70,000 | 11.8M $ | 1.57 % |
| 22 | ARCUS BIOSCIENCES INC | 379,100 | 11.7M $ | 1.56 % |
| 23 | Zimmer Biomet Holdings Inc | 124,000 | 10.7M $ | 1.42 % |
| 24 | Boston Scientific Corp | 250,000 | 10.7M $ | 1.42 % |
| 25 | Sanofi SA | 120,000 | 10.3M $ | 1.37 % |
| 26 | uniQure NV | 217,500 | 10M $ | 1.34 % |
| 27 | Stryker Corp | 30,000 | 9.4M $ | 1.26 % |
| 28 | Incyte Corp | 80,000 | 9.1M $ | 1.21 % |
| 29 | ALNYLAM PHARMACEUTICALS INC | 30,000 | 9M $ | 1.20 % |
| 30 | COGENT BIOSCIENCES INC | 230,000 | 8.9M $ | 1.19 % |
| 31 | Fannie Mae | 1,300,000 | 8.5M $ | 1.13 % |
| 32 | Medtronic PLC | 100,000 | 7.8M $ | 1.04 % |
| 33 | CVS Health Corp | 75,000 | 7.8M $ | 1.03 % |
| 34 | Abbott Laboratories | 80,000 | 7.3M $ | 0.97 % |
| 35 | Quest Diagnostics Inc | 30,000 | 6.4M $ | 0.85 % |
| 36 | AnaptysBio Inc | 93,732 | 6.3M $ | 0.84 % |
| 37 | TARSUS PHARMACEUTICALS INC | 100,000 | 6.3M $ | 0.84 % |
| 38 | FEDERAL HOME LOAN MORTGAGE CORP | 1,050,000 | 6.3M $ | 0.84 % |
| 39 | Rigel Pharmaceuticals Inc | 160,000 | 6.3M $ | 0.83 % |
| 40 | Biogen Inc | 28,000 | 6M $ | 0.81 % |
| 41 | GRAIL Inc | 85,000 | 5.8M $ | 0.77 % |
| 42 | BioMarin Pharmaceutical Inc | 100,000 | 5.7M $ | 0.76 % |
| 43 | Vir Biotechnology Inc | 500,000 | 5.1M $ | 0.68 % |
| 44 | Johnson & Johnson | 20,000 | 5.1M $ | 0.68 % |
| 45 | Monte Rosa Therapeutics Inc | 200,000 | 4.8M $ | 0.65 % |
| 46 | IMMUNOVANT INC | 122,100 | 4.7M $ | 0.63 % |
| 47 | ABIVAX SA | 30,000 | 4M $ | 0.53 % |
| 48 | Syndax Pharmaceuticals Inc | 180,000 | 3.9M $ | 0.52 % |
| 49 | Madrigal Pharmaceuticals Inc | 7,000 | 3.8M $ | 0.50 % |
| 50 | Theravance Biopharma Inc | 208,783 | 3.5M $ | 0.47 % |
| 51 | Xencor Inc | 200,000 | 3.2M $ | 0.43 % |
| 52 | STRUCTURE THERAPEUTICS INC | 58,000 | 3.1M $ | 0.41 % |
| 53 | Perrigo Co PLC | 230,000 | 2.4M $ | 0.32 % |
| 54 | ACADIA Pharmaceuticals Inc | 92,648 | 2.3M $ | 0.31 % |
| 55 | Ultragenyx Pharmaceutical Inc | 70,000 | 2.3M $ | 0.31 % |
| 56 | Compugen Ltd | 1,020,000 | 2.2M $ | 0.29 % |
| 57 | MoonLake Immunotherapeutics | 110,000 | 2.1M $ | 0.29 % |
| 58 | MacroGenics Inc | 420,000 | 1.9M $ | 0.26 % |
| 59 | First Tracks Biotherapeutics Inc | 93,732 | 1.9M $ | 0.25 % |
| 60 | REGENXBIO Inc | 149,000 | 1.8M $ | 0.24 % |
| 61 | BioNTech SE | 18,000 | 1.7M $ | 0.22 % |
| 62 | United Therapeutics Corp | 3,000 | 1.6M $ | 0.22 % |
| 63 | Arvinas Inc | 180,000 | 1.5M $ | 0.20 % |
| 64 | MODERNA INC | 20,000 | 1.4M $ | 0.19 % |
| 65 | CYTOKINETICS INC | 15,000 | 1.3M $ | 0.17 % |
| 66 | COHERUS ONCOLOGY INC | 900,000 | 1.3M $ | 0.17 % |
| 67 | Nektar Therapeutics | 17,092 | 1.2M $ | 0.16 % |
| 68 | Janux Therapeutics Inc | 76,601 | 1.2M $ | 0.16 % |
| 69 | VAXCYTE INC | 20,000 | 1.2M $ | 0.16 % |
| 70 | PROQR THERAPEUTICS NV | 620,000 | 1.2M $ | 0.15 % |
| 71 | Cosmo NV | 14,000 | 1.2M $ | 0.15 % |
| 72 | CELLECTIS SA | 226,875 | 680.6K $ | 0.09 % |
| 73 | Olema Pharmaceuticals Inc | 50,000 | 625.5K $ | 0.08 % |
| 74 | VIRIDIAN THERAPEUTICS INC | 29,370 | 539.5K $ | 0.07 % |
| 75 | Puma Biotechnology Inc | 61,255 | 496.8K $ | 0.07 % |
| 76 | WAVE LIFE SCIENCES LTD | 81,955 | 476.2K $ | 0.06 % |
| 77 | Organon & Co | 29,500 | 399.4K $ | 0.05 % |
| 78 | Instil Bio Inc | 50,000 | 384.5K $ | 0.05 % |
| 79 | Intellia Therapeutics Inc | 20,000 | 338.4K $ | 0.05 % |
| 80 | KARYOPHARM THERAPEUTICS INC | 33,333 | 325.7K $ | 0.04 % |
| 81 | Atea Pharmaceuticals Inc | 70,000 | 325.5K $ | 0.04 % |
| 82 | Allogene Therapeutics Inc | 146,779 | 305.3K $ | 0.04 % |
| 83 | Altimmune Inc | 100,000 | 304K $ | 0.04 % |
| 84 | Myriad Genetics Inc | 50,000 | 285.5K $ | 0.04 % |
| 85 | Rocket Pharmaceuticals Inc | 58,000 | 198.4K $ | 0.03 % |
| 86 | SAREPTA THERAPEUTICS INC | 11,000 | 197.7K $ | 0.03 % |
| 87 | AMARIN CORP PLC | 9,500 | 151.4K $ | 0.02 % |
| 88 | PHIO PHARMACEUTICALS CORP | 50,000 | 51.3K $ | 0.01 % |
| 89 | MIRATI THERAPEUTICS INC | 60,000 | 42K $ | 0.01 % |
| 90 | LITE STRATEGY INC | 30,000 | 27.7K $ | 0.00 % |
| 91 | InnoCare Pharma Ltd | 17,000 | 25.8K $ | 0.00 % |
| 92 | SANGAMO THERAPEUTICS INC | 400,000 | 21.6K $ | 0.00 % |
| 93 | FORTRESS BIOTECH INC | 6,666 | 20.4K $ | 0.00 % |
| 94 | NEXTCURE INC | 12,500 | 20K $ | 0.00 % |
| 95 | Voyager Therapeutics Inc | 5,700 | 20K $ | 0.00 % |
| 96 | Akero Therapeutics Inc | 25,000 | 16.3K $ | 0.00 % |
| 97 | Euroapi SA | 8,695 | 13.3K $ | 0.00 % |
| 98 | GALMED PHARMACEUTICALS LTD | 1,701 | 946.3 $ | 0.00 % |
| 99 | MUSTANG BIO INC | 160 | 112.3 $ |
Sector breakdown
- Health care 64.4 %
- Unattributed 35.6 %
Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".
Currency breakdown
- USD 86.5 %
- EUR 6.9 %
- GBP 3.4 %
- JPY 2.9 %
- CHF 0.2 %
Each line is counted in its quoted currency, as the fund declares it.
Country breakdown
- United States 79.5 %
- Belgium 5.5 %
- United Kingdom 3.5 %
- Japan 2.9 %
- Ireland 2.4 %
- France 2.1 %
- Bermuda 1.7 %
- Netherlands 1.6 %
- Israel 0.3 %
- Cayman Islands 0.3 %
- Germany 0.2 %
- Singapore 0.1 %
Shares are computed on the fund's equities only.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 79 | 565.2M $ | 79.45 % |
| 2 | Belgium | 1 | 39M $ | 5.48 % |
| 3 | United Kingdom | 2 | 24.7M $ | 3.47 % |
| 4 | Japan | 1 | 20.8M $ | 2.92 % |
| 5 | Ireland | 3 | 17.2M $ | 2.41 % |
| 6 | France | 4 | 15M $ | 2.10 % |
| 7 | Bermuda | 1 | 12M $ | 1.68 % |
| 8 | Netherlands | 2 | 11.2M $ | 1.57 % |
| 9 | Israel | 2 | 2.2M $ | 0.31 % |
| 10 | Cayman Islands | 1 | 2.1M $ | 0.30 % |
| 11 | Germany | 1 | 1.7M $ | 0.24 % |
| 12 | Singapore | 1 | 476.2K $ | 0.07 % |
Cite this page
Titelia. "Holdings of Nomura Healthcare Fund". https://titelia.com/en/funds/S000018873